Selection of PI [Regulatives / Guidelines]

posted by Ohlbe – France, 2013-03-19 13:24 (4848 d 05:06 ago) – Posting: # 10236
Views: 2,570

Dear Irukulla,

According to Schedule Y:
All trial Investigator(s) should possess appropriate qualifications, training and experience and should have access to such investigational and treatment facilities as are relevant to the proposed trial protocol. A qualified physician (or dentist, when appropriate) who is an investigator or a sub-investigator for the trial, should be responsible for all trial-related medical (or dental) decisions.

Indian GCP:
§ 3.3.1: The investigator should be qualified by education, training and experience to assume responsibility for the proper conduct of the study and should have qualifications prescribed by the Medical Council of India (MCI).
§ 3.3.2: A qualified Medical Practitioner (or a Dentist, when appropriate) who is an Investigator or a Co-Investigator for the study should be responsible for all study related medical decisions.

ICH GCP, § 4.3.1: A qualified physician (or dentist, when appropriate) who is an investigator or a sub-investigator for the trial, should be responsible for all trial-related medical (or dental) decisions.

In many countries it would not be allowed legally for a pharmacist to be an investigator. In some other countries it may be acceptable for some types of clinical trials (observational...), as long as a medically qualified sub-investigator is available to take medical decisions. For a BE trial I would not consider it appropriate.

Regards
Ohlbe

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
382 visitors (0 registered, 382 guests [including 16 identified bots]).
Forum time: 19:30 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5